*Acanthamoeba*, a genus of free-living amoebae, is widely dispersed in the environment and can be found in natural water bodies, dust, air conditioners, swimming pools and hospitals ([@B14], [@B04], [@B13], [@B03]). The clinical importance of these organisms is related to their ability to cause infections, such as amoebic keratitis, which affects healthy individuals, particularly users of contact lenses. In rare cases, *Acanthamoeba* is the agent responsible for granulomatous amoebic encephalitis (GAE), which is a progressive infection of the central nervous system (CNS) that almost exclusively affects immunocompromised individuals. GAE is characterised by an intense inflammatory response, the invasion of the blood-brain barrier and neurological damage progressing to brain dysfunction, ultimately leading to the death of the patient within days or weeks ([@B17], [@B14], [@B08]).

GAE is initiated by the penetration of the protist intranasally or through a skin lesion ([@B15], [@B16], [@B17]). Being opportunistic agents, *Acanthamoeba* can invade and colonise other tissues, causing disseminated infections that affect the lungs, liver, kidneys, skin, pancreas and prostate, suggesting that the spread of these agents throughout the body occurs haemotogenously ([@B10], [@B10], [@B19]).

Research on the pathogenic potential of *Acanthamoeba* is complicated by the changes induced by prolonged axenic laboratory culture, such as the downregulation of its virulence and encystment capacity and its altered sensitivity to drugs ([@B19], [@B07], [@B12]). These adaptations clearly affect studies on the pathogenic potential and drug susceptibility of *Acanthamoeba* and an effective method to maintain or reactivate the properties of freshly isolated amoebae is highly desirable.

A decrease in the virulence of *Acanthamoeba* is not permanent and can be restored by multiple mouse pas-sages ([@B19]). The present study evaluated the effect of the prolonged culturing of different isolates of *Acanthamoeba* on their invasiveness in a rat model.

MATERIALS AND METHODS
=====================

*Acanthamoeba isolates and cultivation* - Clinical and environmental strains of *Acanthamoeba polyphaga* (AP2 - ATCC 30461 and AP4 - ATCC 30872) and *Acanthamoeba castellanii* (T4 - ATCC 50492 and NEFF - ATCC 30010) were used in this study. The organisms were grown at 30ºC in 2% proteose peptone, 0.2% yeast extract and 1.8% glucose containing antibiotics (penicillin and streptomycin 40 µL/mL) to maintain axenic culture. The ATCC strains used have been grown in this manner in the laboratory since 2006.

*In vivo infection model of Acanthamoeba using intranasal inoculation* - The stimulant solution (SS) for infection was prepared from cultures of different isolates of *Acanthamoeba.* The medium containing 1 x 10^6^ trophozoites/mL was centrifuged at 250 *g* for 10 min. The pellet was washed three times with phosphate buffered saline (PBS) and resuspended in 200 µL of PBS. Adult male Wistar rats, with a mean age of three months, were first immunosuppressed by intraperitoneal injection with dexamethasone (5 mg/kg) ([@B02]). For infection, the animals were anesthetised with ketamine hydrochloride (60 mg/kg) and xylazine hydrochloride (8 mg/kg) and were inoculated intranasally with 200 µL of the SS. After infection, the animals were observed for 30 days. After this period, the rats were euthanised by depression of oxygen and the organs were removed and evaluated under a magnifying glass to observe the lesions. All experiments were performed in duplicate. Two animals were used as controls and were submitted to the same conditions as the test group. The parasites were re-isolated from the organ lesions and cultured in plates with non-nutrient agar 1.5% covered with inactivated *Escherichia coli* (ATCC 25922). Only the T4r and AP4r re-isolates were re-inoculated into animals.

*Ethics* - This study had been previously approved by the Ethical Committee on Animal Studies at the Federal University of Rio Grande do Sul.

*Histological analysis* - The organs were removed from the infected animals and preserved in 4% paraformaldehyde. Later, sections were obtained for histological analysis and protist visualisation in tissue. Haematoxylin and eosin were used to stain the sections.

RESULTS
=======

All the ATCC isolates studied, i.e., T4 (50492), AP2 (30461), AP4 (30872) and NEFF (30010), were able to establish systemic infections in the rats. The lesions produced by AP2 (30461) and NEFF (30010) were disseminated in several organs and caused the deaths of the animals after an average period of 26 days. The lesions produced by AP4 (30872) and T4 (50492) were restricted to the lungs and these animals survived for the 30-day duration of the experiment ([Table](#t01){ref-type="table"}). For the rats infected with T4r and AP4r, the mean survival time after infection was 17 days ([Table](#t01){ref-type="table"}). Generally, it can be assumed that the rats survived for shorter periods when the infections were more invasive. The two animals used as controls survived the 30-day period of the experiment and *post-mortem* examination revealed no injury to their organs. *Acanthamoeba* were not isolated from the tissues obtained from the control rats.

TABLEEvaluation of in vivo model of Acanthamoeba infectionIsolation in organsIsolatedLungsBrainLiverHeartKidneysDays of survival post-infectionT4+\-\-\--30AP2+-+-+22AP4+\-\-\--30NEFF+-+\--30T4r++-++20AP4r+++++15[^1]

All of the *Acanthamoeba* isolates, whether clinical or environmental, were able to establish systemic infections in the immunosuppressed animals, where they mainly reached the lungs, as shown in [Fig. 1](#f01){ref-type="fig"}. The animals infected with the standard strains, i.e., AP2 (30461) and NEFF (30010), suffered more invasive infections. The parasite was re-isolated from the lungs, liver and kidneys of rats infected with the ATCC strain 30461, as well as from the liver and lungs of rats infected with the ATCC strain 30010 ([Table](#t01){ref-type="table"}). When the trophozoites that were re-isolated from lesions were used, i.e., AP4r and T4r, the protists were found in several organs, including the brain ([Table](#t01){ref-type="table"}). The symptoms were perceived 10 days after infection and mainly consisted of weight loss, hair loss, shivering, diarrhoea and prostration.

Fig. 1representative pictures of lungs of rats infected intranasally with Acanthamoeba . A: lungs normal tissue, rats not infected with Acanthamoeba ; B: lungs tissue with confirmed Acanthamoeba infection; C: histological analysis of tissue the lungs with Acanthamoeba contamination. The arrows point to two trophozoites. Magnification 400X.

The brains of all the infected animals were removed and observed. Only the brains of animals infected with re-isolated AP4r and T4r showed altered morphology ([Fig. 2](#f02){ref-type="fig"}). The parasites were observable in the histological analyses ([Fig. 2](#f02){ref-type="fig"}).

Fig. 2representative pictures of brain of rats infected intranasally with Acanthamoeba . A: brain normal tissue, rats not infected with Acanthamoeba ; B: brain tissue with confirmed Acanthamoeba infection (T4r re-isolate); C: histological analysis of tissue the brain with Acanthamoeba contamination. The arrows point the trophozoite. Magnification 400X.

DISCUSSION
==========

During human infection, strains of *Acanthamoeba* affect several organs in addition to the brain, including the skin, liver, lungs, kidneys, heart, diaphragm, eyes, adrenal glands, pancreas, prostate, lymph nodes and bone marrow ([@B20], [@B09], [@B25]). [@B22] studied *Acanthamoeba* infections in locusts and observed that the insects developed disseminated infections in the haemolymph, fat body, muscle and brain tissues. In another study, *Acanthamoeba* were found in the lungs and brain tissue of mice ([@B05]). The results of the present study showed that this infection model produced systemic infections in rats and that several organs were affected (Table).

According to Khan (2010), the ability of *Acanthamoeba* to cause systemic infections reflects its capacity to survive, attack the innate immune system and invade the CNS, which is consistent with GAE cases in humans. Our results show that strains isolated from the environment can cause infections that are quite similar to those caused by the clinical strains of *Acanthamoeba* (Table), which poses a potential risk to human health, especially in immunosuppressed individuals. This risk is consistent with the results of [@B05], who found that strains previously described as incapable of causing infections in mice were highly pathogenic and caused 100% mortality in animals that were inoculated intracerebrally.

When recent isolates of *Acanthamoeba* were used to infect rats, the animals developed more invasive and rapidly fatal infections. For *Leishmania* spp, maintenance in vitro results in a progressive loss of virulence, which can be reversed by passage in a mammalian host. A significant correlation has also been found between higher parasite burdens in infected Balb/c mice and fewer in vitro passages of the amoebae ([@B21]). Therefore, the different invasive capacities of *Acanthamoeba* isolates and re-isolates can be explained by the expression of different virulence factors after the first infection.

[@B18] compared the pathological and morphological changes in the organs of rats caused by infection with strains of low and high virulence in vivo. These investigators reported that infections with each *Acanthamoeba* isolate resulted in similar infections, but that the changes induced by the strain with low virulence developed later and were less extensive. They suggested that differences in the virulence of strains, due to the reactivation of factors, could explain why only the re-isolated amoebae reached the brain of the rats. Another study demonstrated that parasites that had been grown for different periods of axenic in vitro culture induced different infections in rats ([@B21]).

Studies in the 1970s demonstrated that when studying *Acanthamoeba,* pathogenicity tests should be performed as soon as possible after isolation because the strains lose virulence with frequent transfers in axenic culture ([@B24]). [@B21] noted that axenic culturing and long-term maintenance of the parasite can affect the outcome of in vitro infections. This influence was also demonstrated in in vivo studies by [@B06], who determined the degrees of virulence for six strains of *Acanthamoeba* in mice based on the number of organs affected and the extent of histopathological changes due to systemic infections. Using this criterion, the strains studied here were classified with varying degrees of virulence. As such, ATCC strains AP2 (30461) and NEFF (30010) were more virulent and T4 (30492) and AP4 (30872) were less virulent. Additionally, the T4r and AP4r re-isolates became more virulent after the first infection in animals.

Although in vitro models are more practical and efficient in restoring the virulence of *Acanthamoeba* ([@B11]), this study utilised an in vivo model because, even with immunosuppressed animals, the parasites must address different host defence mechanisms, which can result in the expression of different virulence factors and the selection of resistant forms. The capacity of the parasite to modulate macrophage activation decreases significantly with increasing numbers or intervals of in vitro passages ([@B01], [@B23], [@B21]).

The observed changes in the profiles of proteolytic activity between the isolates cultured in the laboratory for long periods and those recently passed through an animal model (data not shown), as well as the increase in the severity of the infections caused by these re-isolates, indicate that the first contact with animals may have induced changes in the expression of the virulence factors.

Our results provide further evidence for the effect of prolonged axenic culture on the virulence of *Acanthamoeba*. They indicate the importance of developing protocols to reactivate the virulence of *Acanthamoeba* cultures in studies focusing on interactions with mammals, such as drug development or vaccine trial studies and pathogenicity.
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[^1]: AP2: ATCC 30461; AP4: ATCC 30872; NEFF: ATCC 30010; T4: ATCC 50492.
